Can We Clarify the Causative Gene/Variants Underlying Familial Hypercholesterolemia and Improve Genetic Diagnosis Rate?
- PMID: 34408116
- PMCID: PMC9135654
- DOI: 10.5551/jat.ED184
Can We Clarify the Causative Gene/Variants Underlying Familial Hypercholesterolemia and Improve Genetic Diagnosis Rate?
Comment on
-
Genetic Analysis in a Taiwanese Cohort of 750 Index Patients with Clinically Diagnosed Familial Hypercholesterolemia.J Atheroscler Thromb. 2022 May 1;29(5):639-653. doi: 10.5551/jat.62773. Epub 2021 May 16. J Atheroscler Thromb. 2022. PMID: 33994402 Free PMC article.
References
-
- Benn M, Watts GF, Tybjærg-Hansen A and Nordestgaard BG: Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217. Euro Heart J, 2016; 37: 1384-1394 - PubMed
-
- Chiou K-R and Charng M-J: Genetic diagnosis of familial hypercholesterolemia in Han Chinese. J Clin Lipidol, 2016; 10: 490-496 - PubMed
-
- Hori M, Ohta N, Takahashi A, Masuda H, Isoda R, Yamamoto S, Son C, Ogura M, Hosoda K, Miyamoto Y and Harada-Shiba M: Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients. Atherosclerosis, 2019; 289: 101-108 - PubMed
